These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15676038)

  • 1. Equivalent lung deposition of budesonide in vivo: a comparison of dry powder inhalers using a pharmacokinetic method.
    Lähelmä S; Kirjavainen M; Kela M; Herttuainen J; Vahteristo M; Silvasti M; Ranki-Pesonen M
    Br J Clin Pharmacol; 2005 Feb; 59(2):167-73. PubMed ID: 15676038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two budesonide dry powder inhalers in the treatment of asthma in children.
    Vanto T; Hämäläinen KM; Vahteristo M; Wille S; Njå F; Hyldebrandt N;
    J Aerosol Med; 2004; 17(1):15-24. PubMed ID: 15120009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study for the establishment of bioequivalence of two inhalation treatments containing budesonide plus formoterol.
    Grekas N; Athanassiou K; Papataxiarchou K; Rizea Savu S; Silvestro L
    J Pharm Pharmacol; 2014 Dec; 66(12):1677-85. PubMed ID: 25109416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the systemic effects of budesonide inhaled from Easyhaler and from Turbuhaler in healthy male volunteers.
    Hämäläinen KM; Granander M; Toivanen P; Malinen A
    Respir Med; 2001 Nov; 95(11):863-9. PubMed ID: 11716199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers.
    Persson G; Ankerst J; Gillen M; Bengtsson T; Thorsson L
    Curr Med Res Opin; 2008 May; 24(5):1511-7. PubMed ID: 18419877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two budesonide powder inhalers, Easyhaler and Turbuhaler, in steroid-naïve asthmatic patients.
    Schweisfurth H; Malinen A; Koskela T; Toivanen P; Ranki-Pesonen M;
    Respir Med; 2002 Aug; 96(8):599-606. PubMed ID: 12195841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic comparison of budesonide deposition from two dry powder inhalers.
    Newman SP; Pitcairn GR; Hirst PH; Bacon RE; O'Keefe E; Reiners M; Hermann R
    Eur Respir J; 2000 Jul; 16(1):178-83. PubMed ID: 10933104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers.
    Munzel U; Marschall K; Fyrnys B; Wedel M
    Curr Med Res Opin; 2005 Jun; 21(6):827-33. PubMed ID: 15969882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability and acceptability of two dry powder inhalers in the administration of budesonide in steroid-treated asthmatic patients.
    Tukiainen H; Rytilä P; Hämäläinen KM; Silvasti MS; Keski-Karhu J;
    Respir Med; 2002 Apr; 96(4):221-9. PubMed ID: 12000000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation.
    Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children.
    Agertoft L; Pedersen S
    Am J Respir Crit Care Med; 2003 Oct; 168(7):779-82. PubMed ID: 12893646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique.
    Warren S; Taylor G; Smith J; Buck H; Parry-Billings M
    J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salbutamol via Easyhaler is at least as effective as salbutamol via Turbuhaler in the treatment of histamine-induced bronchoconstriction.
    Zetterström O; Lähelmä S; Keski-karhu J; Silvasti M; Ostling-kulling E; Ahonen A
    Respir Med; 2000 Nov; 94(11):1097-102. PubMed ID: 11127498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients.
    Hirst PH; Bacon RE; Pitcairn GR; Silvasti M; Newman SP
    Respir Med; 2001 Sep; 95(9):720-7. PubMed ID: 11575892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
    Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
    Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung deposition of budesonide from the novel dry powder inhaler Airmax.
    Hirst RH; Newman SR; Clark DA; Hertog MG
    Respir Med; 2002 Jun; 96(6):389-96. PubMed ID: 12117037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
    Pitcairn G; Reader S; Pavia D; Newman S
    J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.
    Duddu SP; Sisk SA; Walter YH; Tarara TE; Trimble KR; Clark AR; Eldon MA; Elton RC; Pickford M; Hirst PH; Newman SP; Weers JG
    Pharm Res; 2002 May; 19(5):689-95. PubMed ID: 12069174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.